Literature DB >> 21874413

The significance of lymph node status as a prognostic factor for esophageal cancer.

Yasunori Akutsu1, Hisahiro Matsubara.   

Abstract

The revision of the TNM Classification of Malignant Tumors, 7th Edition, suggests the lymph node (LN) status to be the most significant risk factor in esophageal cancer. This article reviews the current status of LNs as indicators of prognosis. The significance of the number of metastatic LNs, the number of resected LNs, and a novel index, the "LN ratio" (metastatic LNs/removed LNs) in patients with esophageal cancer, were reviewed. The number of metastatic LNs independently predicted the prognosis of both overall survival and relapse-free survival. The number of positive LNs was also the best predictive marker of survival. Furthermore, overall survival significantly depended on the number of surgically removed LNs, and the LN ratio closely correlated with survival. The LN status is considered to be the most significant information that can be used to predict the prognosis. However, there are many issues that still need to be resolved. Better knowledge of the N-status is therefore needed to effectively utilize this information. Further research should focus on the N-status of patients with esophageal cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21874413     DOI: 10.1007/s00595-011-4542-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  56 in total

1.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Authors:  John D Urschel; Hari Vasan
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

2.  The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.

Authors:  Nabil Rizk; Ennapadam Venkatraman; Bernard Park; Raja Flores; Manjit S Bains; Valerie Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2006-12       Impact factor: 5.209

3.  Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer.

Authors:  T Nishimaki; O Tanaka; N Ando; H Ide; H Watanabe; M Shinoda; W Takiyama; H Yamana; K Ishida; K Isono; M Endo; T Ikeuchi; T Mitomi; H Koizumi; M Imamura; T Iizuka
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

4.  Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography.

Authors:  M A Eloubeidi; M B Wallace; B J Hoffman; M B Leveen; A Van Velse; R H Hawes; C E Reed
Journal:  Ann Thorac Surg       Date:  2001-07       Impact factor: 4.330

5.  Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.

Authors:  Thomas W Rice; Valerie W Rusch; Hemant Ishwaran; Eugene H Blackstone
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

6.  Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer.

Authors:  Brendon M Stiles; Paul Christos; Jeffrey L Port; Paul C Lee; Subroto Paul; James Saunders; Nasser K Altorki
Journal:  J Thorac Cardiovasc Surg       Date:  2009-12-16       Impact factor: 5.209

7.  Does systematic 2-field lymphadenectomy for esophageal malignancy offer a survival advantage? Results from 178 consecutive patients.

Authors:  D J Martin; N G Church; C W Kennedy; G L Falk
Journal:  Dis Esophagus       Date:  2008-05-02       Impact factor: 3.429

8.  Prognosis after surgical resection of M1a/M1b esophageal squamous cell carcinoma.

Authors:  Young Mog Shim; Yong Soo Choi; Kwhanmien Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

9.  Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study.

Authors:  Yoshihiro Tanaka; Kazuhiro Yoshida; Yuichi Sanada; Shinji Osada; Kazuya Yamaguchi; Takao Takahashi
Journal:  Cancer Chemother Pharmacol       Date:  2010-09-28       Impact factor: 3.333

10.  The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer.

Authors:  Wen-Hu Hsu; Po-Kuei Hsu; Chih-Cheng Hsieh; Chien-Sheng Huang; Yu-Chung Wu
Journal:  J Gastrointest Surg       Date:  2009-08-12       Impact factor: 3.452

View more
  28 in total

1.  Endoscopic ultrasound-guided elastography in the nodal staging of oesophageal cancer.

Authors:  Stuart Paterson; Fraser Duthie; Adrian J Stanley
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  Minimally invasive esophagectomy for esophageal cancer: an updated review.

Authors:  Masayuki Watanabe; Yoshifumi Baba; Yohei Nagai; Hideo Baba
Journal:  Surg Today       Date:  2012-08-28       Impact factor: 2.549

3.  Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.

Authors:  M J Fernández-Aceñero; M Granja; J Sastre; B García-Paredes; L Estrada
Journal:  Virchows Arch       Date:  2016-01-11       Impact factor: 4.064

4.  Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery.

Authors:  Bo Ye; Chen-Xi Zhong; Yu Yang; Wen-Tao Fang; Teng Mao; Chun-Yu Ji; Zhi-Gang Li
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

5.  Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio.

Authors:  Jianfang Liu; Zhu Wang; Huafei Shao; Dong Qu; Jian Liu; Libo Yao
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

Review 6.  Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.

Authors:  Harushi Udagawa; Masaki Ueno
Journal:  Ann Transl Med       Date:  2018-02

7.  The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer.

Authors:  Jinrong Qu; Chen Shen; Jianjun Qin; Zhaoqi Wang; Zhenyu Liu; Jia Guo; Hongkai Zhang; Pengrui Gao; Tianxia Bei; Yingshu Wang; Hui Liu; Ihab R Kamel; Jie Tian; Hailiang Li
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

Review 8.  Lymph node dissection for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26

9.  Clinical Significance of the Pre-therapeutic Nodal Size in Patients Undergoing Neo-Adjuvant Treatment Followed by Esophagectomy for Esophageal Squamous Cell Carcinoma.

Authors:  Shinji Mine; Masayuki Watanabe; Yu Imamura; Akihiko Okamura; Takanori Kurogochi; Takeshi Sano
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 10.  Accuracy of sentinel node biopsy in esophageal carcinoma: a systematic review and meta-analysis of the pertinent literature.

Authors:  Vahid Reza Dabbagh Kakhki; Reza Bagheri; Shahrzad Tehranian; Pardis Shojaei; Hassan Gholami; Ramin Sadeghi; David N Krag
Journal:  Surg Today       Date:  2013-05-29       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.